In-Q-Tel investment in Colossal Biosciences
IN-Q-TEL, SEP 2022
Source verified
What the document is
In-Q-Tel, the venture capital arm that invests on behalf of the United States intelligence community, took a position in Colossal Biosciences, the de-extinction and genetic engineering company co-founded with geneticist George Church.
Why it is in the report
It is a documented line between an intelligence funding vehicle and frontier genetic engineering, and it landed the same month as the biotechnology executive order.
What this document does not say. An In-Q-Tel investment signals interest in a technology area. It is not evidence of a classified program, and the library does not claim one.
Pull it yourself
- Open the In-Q-Tel portfolio page and search for Colossal.
- Check Colossal's own investor announcements.
- Compare the announcement date with the date of EO 14081.
Cite this record
In-Q-Tel. In-Q-Tel investment in Colossal Biosciences. Venture investment, 2022-09-01. https://www.iqt.org/portfolio
